Factors associated with HPV vaccine uptake in teenage girls: a systematic review (Q38000427)

26 August 2017

title

Factors associated with HPV vaccine uptake in teenage girls: a systematic review (English)

1 reference

26 August 2017

1 reference

1 reference

1 reference

Annette Braunack-Mayer

object named as

Annette J Braunack-Mayer

4

0 references

Helen Marshall

object named as

Helen S Marshall

2

0 references

author name string

Sharon J M Kessels

1

1 reference

26 August 2017

Maureen Watson

3

1 reference

26 August 2017

Rob Reuzel

5

1 reference

26 August 2017

Rebecca L Tooher

6

1 reference

26 August 2017

language of work or name

English

0 references

publication date

3 April 2012

1 reference

26 August 2017

1 reference

26 August 2017

volume

30

1 reference

26 August 2017

issue

24

1 reference

26 August 2017

page(s)

3546-3556

1 reference

Protecting the next generation: what is the role of the duration of human papillomavirus vaccine-related immunity?

26 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.03.063

Human papillomavirus vaccines: current status and future prospects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.03.063

Quadrivalent human papillomavirus (HPV) vaccine: a review of safety, efficacy, and pharmacoeconomics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.03.063

Efficacy, duration of immunity and cross protection after HPV vaccination: a review of the evidence

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.03.063

An overview on the implementation of HPV vaccination in Europe

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.03.063

Efficacy of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.03.063

Voluntary school-based human papillomavirus vaccination: an efficient and acceptable model for achieving high vaccine coverage in adolescents.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.03.063

A systematic review of measures used in studies of human papillomavirus (HPV) vaccine acceptability.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.03.063

Predictors of HPV vaccine acceptability: a theory-informed, systematic review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.03.063

Integrating clinical, community, and policy perspectives on human papillomavirus vaccination

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.03.063

Factors influencing familial decision-making regarding human papillomavirus vaccination

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.03.063

Correlates for completion of 3-dose regimen of HPV vaccine in female members of a managed care organization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.03.063

Factors associated with initiation and completion of human papillomavirus vaccine series among young women enrolled in Medicaid

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.03.063

Patient and clinic factors associated with adolescent human papillomavirus vaccine utilization within a university-based health system.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.03.063

Human papillomavirus and cervical cancer: Gardasil vaccination status and knowledge amongst a nationally representative sample of Australian secondary school students.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.03.063

A population-based evaluation of a publicly funded, school-based HPV vaccine program in British Columbia, Canada: parental factors associated with HPV vaccine receipt

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.03.063

Human papillomavirus vaccination and social inequality: results from a prospective cohort study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.03.063

Longitudinal predictors of human papillomavirus vaccine initiation among adolescent girls in a high-risk geographic area

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.03.063

Understanding the reasons why mothers do or do not have their adolescent daughters vaccinated against human papillomavirus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.03.063

Parental response to human papillomavirus vaccine availability: uptake and intentions.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.03.063

Factors influencing HPV vaccination status in a Latino population; and parental attitudes towards vaccine mandates.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.03.063

Correlates for human papillomavirus vaccination of adolescent girls and young women in a managed care organization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.03.063

Patient—Provider Communication and Human Papillomavirus Vaccine Acceptance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.03.063

Parental Decision Making about the HPV Vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.03.063

Geographic disparity, area poverty, and human papillomavirus vaccination

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.03.063

Statewide HPV vaccine initiation among adolescent females in North Carolina

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.03.063

Influential factors in HPV vaccination uptake among providers in four states

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.03.063

Coverage and compliance of Human Papilloma Virus vaccines in Paris: demonstration of low compliance with non-school-based approaches

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.03.063

Disparities in human papillomavirus vaccine series initiation among adolescent girls enrolled in Florida Medicaid programs, 2006-2008.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.03.063

Determinants for HPV vaccine uptake in the Netherlands: A multilevel study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.03.063

Knowledge and early adoption of the HPV vaccine among girls and young women: results of a national survey

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.03.063

Uptake of HPV vaccine: demographics, sexual history and values, parenting style, and vaccine attitudes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.03.063

Participation in the decision to become vaccinated against human papillomavirus by California high school girls and the predictors of vaccine status

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.03.063

How parents hear about human papillomavirus vaccine: implications for uptake

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.03.063

A survey of adolescent experiences of human papillomavirus vaccination in the Manchester study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.03.063

Parental attitudes and information needs in an adolescent HPV vaccination programme

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.03.063

Papanicolaou screening behavior in mothers and human papillomavirus vaccine uptake in adolescent girls

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.03.063

Factors associated with completion of the human papillomavirus vaccine series

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.03.063

Adherence to the HPV vaccine dosing intervals and factors associated with completion of 3 doses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.03.063

Scaling up human papillomavirus vaccination: a conceptual framework of vaccine adherence

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.03.063

Socioeconomic status, demographics, beliefs and A(H1N1) vaccine uptake in the United States

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.03.063

Hepatitis B vaccination coverage among U.S. adolescents, National Immunization Survey-Teen, 2006.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.03.063

Factors affecting intention to receive and self-reported receipt of 2009 pandemic (H1N1) vaccine in Hong Kong: a longitudinal study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.03.063

Vaccination coverage in 14-year-old adolescents: documentation, timeliness, and sociodemographic determinants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.03.063

Determinants of universal adolescent hepatitis B vaccine uptake

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.03.063

Racial and ethnic disparities in cervical cancer incidence rates in the United States, 1992-2003.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.03.063

The disparity of cervical cancer in diverse populations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.03.063

Country recommendations on the inclusion of HPV vaccines in national immunization programmes among high-income countries, June 2006-January 2008.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.03.063

Timing of hepatitis B vaccination: its effect on vaccine response in health care workers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.03.063

HPV vaccine acceptability in a rural Southern area

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.03.063

Acceptability of a human papillomavirus (HPV) trial vaccine among mothers of adolescents in Cuernavaca, Mexico

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.03.063

Anticipated acceptance of HPV vaccination at the baseline of implementation: a survey of parental and adolescent knowledge and attitudes in Finland

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.03.063

Disparities in how parents are learning about the human papillomavirus vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.03.063

Parents' health beliefs and HPV vaccination of their adolescent daughters

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.03.063

Correlates of receiving recommended adolescent vaccines among adolescent females in North Carolina

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.03.063

Uptake of first two doses of human papillomavirus vaccine by adolescent schoolgirls in Manchester: prospective cohort study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.03.063

10.1016/J.VACCINE.2012.03.063

7 January 2021

Identifiers

DOI

1 reference

26 August 2017

1 reference